Assaf, C. (2009) “Zanolimumab (HuMax-CD4®), a fully human monoclonal antibody in clinical development for cutaneous T-cell lymphoma”, Hematology Meeting Reports (formerly Haematologica Reports), 2(5). doi: 10.4081/hmr.v2i5.736.